HZNP
Natixis Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-25,267
| Closed | -$2.76M | – | 1536 |
|
2023
Q1 | $2.76M | Sell |
25,267
-111,900
| -82% | -$12.2M | 0.01% | 857 |
|
2022
Q4 | $15.6M | Sell |
137,167
-23,148
| -14% | -$2.63M | 0.06% | 355 |
|
2022
Q3 | $9.92M | Sell |
160,315
-66,445
| -29% | -$4.11M | 0.04% | 436 |
|
2022
Q2 | $18.1M | Sell |
226,760
-2,268
| -1% | -$181K | 0.08% | 291 |
|
2022
Q1 | $24.1M | Buy |
229,028
+52,675
| +30% | +$5.54M | 0.09% | 243 |
|
2021
Q4 | $19M | Buy |
176,353
+6,788
| +4% | +$731K | 0.07% | 294 |
|
2021
Q3 | $18.6M | Buy |
169,565
+33,063
| +24% | +$3.62M | 0.08% | 268 |
|
2021
Q2 | $12.8M | Buy |
136,502
+58,577
| +75% | +$5.49M | 0.06% | 344 |
|
2021
Q1 | $7.17M | Buy |
77,925
+11,299
| +17% | +$1.04M | 0.04% | 478 |
|
2020
Q4 | $4.87M | Buy |
66,626
+1,853
| +3% | +$136K | 0.03% | 566 |
|
2020
Q3 | $5.03M | Sell |
64,773
-488
| -0.7% | -$37.9K | 0.03% | 521 |
|
2020
Q2 | $3.63M | Buy |
+65,261
| New | +$3.63M | 0.02% | 612 |
|